Trials / Terminated
TerminatedNCT03085394
Preoperative Hexakapron Reduces Bleeding in Bariatric Surgery
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 152 (actual)
- Sponsor
- Sheba Medical Center · Other Government
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Prophylactic use of tranexamic acid to reduce intra and postoperative bleeding in primary sleeve gastrectomy procedures will be studied.
Detailed description
Patients scheduled for primary laparoscopic sleeve gastrectomy for the treatment of morbid obesity will be assigned to receive tranexamic acid vs. placebo before surgery. Intraoperative bleeding will be scored, as well as postoperative bleeding and blood or blood-product requirements. POstoperative venous thromboembolic events will be recorded up to 2 months following surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | tranexamic acid | Preoperative intravenous administration of 2 grams tranexamic acid in 10 ml saline |
| DRUG | Placebo | Preoperative intravenous administration of 10 ml saline |
Timeline
- Start date
- 2017-09-01
- Primary completion
- 2022-11-21
- Completion
- 2022-11-21
- First posted
- 2017-03-21
- Last updated
- 2023-04-19
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT03085394. Inclusion in this directory is not an endorsement.